CVD = cardiovascular disease; DKA = diabetic ketoacidosis; DKD = diabetic kidney disease; NASH = nonalcoholic steatohepatitis; RAs = receptor agonists; SQ = subcutaneous; T2DM = type 2 diabetes.

†FDA approved for CVD benefit
*Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015; 38:140–149